Use Of Granisetron For The Treatment Of Sub-types Of Rosacea, And Pharmaceutical Compositions Containing Same

Abstract

The invention relates to the use of granisetron or the salts thereof as an active substance in a pharmaceutical composition, especially a dermatological composition. The composition is preferably applied topically and is used for the treatment and/or prevention of papulopustular rosacea, phymatous rosacea and/or ocular rosacea.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Mar 27, 2008
  • Application: May 31, 2007
    WO FR 2007051360 W
  • Priority: May 31, 2006
    FR FR 0651983 A

Sign in to the Lens